Mouth breathing statistics, 2026

There is no national surveillance program for mouth breathing, so every figure below comes from a cross-sectional study, a clinical cohort, or a meta-analysis of those. Sample sizes, countries, and diagnostic methods differ, and the spread in the results reflects that.

• 44% pooled prevalence in children (95% CI 38-49) across studies totalling 1,182 participants (Savian et al., Clinical Oral Investigations 2021).
• 55% (204 of 370 children aged 3-9) in a representative randomized cross-sectional study in Abaete, Brazil (Abreu et al., Jornal de Pediatria 2008).
• 27.7% (95 of 343) among 8-9 year-old elementary schoolchildren in Bandung, Indonesia (Primarti et al., 2025).
• 15.6% (40 of 257) among 3-5 year-olds in a Brazilian preschool sample (Soares et al., Brazilian Oral Research 2024).
• 11-56% is the full published range for children, per the 2024 review that assessed two decades of literature (Zhang et al., Frontiers in Public Health 2024).
• 61.8% of pediatric orthodontic patients were reported as mouth breathers in a 2026 multicenter cross-sectional study, with snoring in 26.9% and screened sleep-disordered breathing in 13.4% (Journal of Clinical Medicine 2026). Note this is a clinic-referred sample, so it is not a population estimate.

The practical read: in a typical primary-school classroom, somewhere between one in nine and one in two children are habitual mouth breathers depending on how you count. Even the conservative end of that range is larger than the prevalence of childhood asthma.

Adult data is thinner than pediatric data, largely because mouth breathing in adults is usually studied as a feature of sleep apnea rather than as a condition in its own right.

• Estimated prevalence of 26% in the adult population, rising to 45-57% in people with obesity (Su et al., Biomedical Journal 2022).
• In a sleep-lab comparison of 60 OSA patients against 15 healthy controls, the OSA group spent 96.7% of total sleep time with the mouth open versus 26.7% in controls, and were in complete mouth breathing for 14.1% of the night versus 2.7% (Su et al., 2022).
• Waking dry mouth is reported by 22.4% to 40.7% of OSA patients, and the proportion scales with severity (Su et al., 2022).
• The same study measured overnight fluid loss: OSA patients lost an estimated 5.5% of plasma volume across the night versus 3.7% in controls, with the extent of mouth breathing correlating with the loss (Spearman rho = 0.262, p = 0.023).

This is the cluster with the strongest and most consistent effect sizes in the literature. Mouth breathing and sleep-disordered breathing travel together closely enough that several pediatric screening instruments use mouth breathing as a proxy question.

• Mouth-breathing schoolchildren were 4.24 times as likely to screen positive for sleep-disordered breathing (95% CI 2.70-6.65, p < 0.001). In absolute terms, 41.1% of mouth breathers screened positive versus 9.7% of non-mouth-breathers (Primarti et al., 2025).
• Mean Pediatric Sleep Questionnaire affirmative-response rate was 25.45% in mouth breathers versus 7.93% in non-mouth-breathers (p < 0.001, Mann-Whitney).
• In the pediatric orthodontic cohort, screened sleep-disordered breathing was independently associated with ADHD combined subtype (OR 6.22), hyperactive/impulsive symptoms (OR 5.84), oppositional-defiant disorder (OR 4.91), and anxiety or depression (OR 4.38) (J Clin Med 2026).
• In a population-based birth cohort, snoring or OSA symptoms were associated with roughly a twofold difference in odds of ADHD diagnosis or symptoms, and OSA symptoms with a threefold to fourfold difference in odds of conduct problems (Bonuck et al., Pediatrics 2012).
• Peak sleep-disordered-breathing symptoms at 30 months predicted hyperactivity (OR 1.85; 1.30-2.63), conduct problems (OR 1.60; 1.18-2.16), and peer difficulties (OR 1.37; 1.04-1.80) at age 7, controlling for 15 confounders (Pediatrics 2012).

A caution worth stating plainly: these are associations. The landmark Childhood Adenotonsillectomy Trial randomized children with OSA to early surgery or watchful waiting and found improvements in behavior, quality of life, and polysomnography, but no significant improvement in the primary cognitive endpoint (attention and executive function on NEPSY). Fixing the breathing does not automatically fix the test scores.

The claim that chronic mouth breathing reshapes the growing face is the most repeated and least carefully sourced claim in this entire topic. Here is what the measured data actually shows, including where it is weaker than commonly presented.

• In 3,586 fifteen-year-olds from the ALSPAC cohort assessed with 3D facial imaging, the sleep-disordered-breathing group showed increased mandible angle (+0.86 degrees, p < 0.001), increased lower face height (+0.28 mm), reduced nose prominence, and reduced nose width (Al Ali et al., BMJ Open 2015).
• Adjusted for BMI, the odds ratios were 1.11 for increased mandible angle (p = 0.001) and 1.09 for increased face height (p = 0.011). Real, consistent, and small.
• 81.4% of mouth breathers presented with Class II malocclusion in a cross-sectional study cited in the 2024 adenoid facies review, alongside increased overjet, posterior crossbite, high palatal vault, and narrow arches (Zhang et al., 2024).
• Lateral compression of the upper dental arch has been observed in children with deciduous dentition as early as 2.5 years of age, and adenoids reach maximum size between 6 and 10 years - the window that matters most for intervention timing (Zhang et al., 2024).
• Mouth breathing is associated with increased craniocervical extension, a compensatory head posture that maintains airway patency and is itself a driver of the altered growth vector (oral breathing and dentofacial development review, 2025).

The honest summary: the direction of effect is well replicated, the mechanism is plausible, and the average magnitude in unselected populations is under a millimetre and under a degree. Anyone showing you a dramatic facial transformation and attributing it solely to breathing route is showing you an outlier or an intervention that included orthodontics.

This cluster has the most direct clinical measurements, because dentists see the consequences first and have been measuring them for decades.

• Mouth breathing was associated with anterior dental caries in preschoolers at an adjusted prevalence ratio of 1.57 (95% CI 1.01-2.46, p = 0.047). Caries affected 40% of mouth breathers versus 30.7% of nasal breathers (Soares et al., Braz Oral Res 2024).
• After scaling and root planing for chronic periodontitis, mouth breathers showed significantly worse healing at palatal sites: 38% of deep bleeding sites resolved versus 69% in nose breathers (p < 0.05, n = 60) (Kaur et al., BDJ Open 2018).
• Bleeding on probing improved by 16.69% in mouth breathers versus 25.88% in nose breathers by week four of the same trial.
• The mechanism is measurable: in mouth breathers, water evaporating from saliva can reach 0.24 mL/min, increasing bacterial retention and gingival inflammation (periodontal disease in mouth-breathing patients, literature review).
• The association between mouth breathing and gingivitis is concentrated in the maxillary anterior region and persists after adjusting for gender, crowding, and plaque quantity (Wagaiyu & Ashley, J Clin Periodontol 1991).
• In adolescents, lip-closing force, tongue pressure, and masticatory efficiency all declined in the order nasal breather, oronasal breather, mouth breather. Tongue pressure was the only significant independent variable (OR 1.063; 95% CI 1.006-1.123, p < 0.05) (Scientific Reports 2024).

The functional argument for nasal breathing rests on a specific, measurable piece of physiology: the paranasal sinuses continuously produce nitric oxide, and that gas only reaches the lungs on a nasal inhale.

• Nitric oxide is produced in the paranasal sinuses and excreted continuously into the nasal airway, reaching the lungs with inspiration during nasal breathing (Lundberg, The Anatomical Record 2008).
• Nasally derived NO increases arterial oxygen tension and reduces pulmonary vascular resistance, acting as what Lundberg's group termed an airborne messenger (Lundberg et al., Acta Physiol Scand 1996).
• In that study, transcutaneous oxygen tension was approximately 10% higher during nasal breathing than oral breathing in six of eight healthy subjects, and pulmonary vascular resistance fell by 11% in four of twelve intubated patients when nasal air was added to the inhaled gas.
• Tracheotomized-patient studies confirmed the nasal rather than oral origin of the inhaled NO fraction (European Respiratory Journal 2002).

Worth being precise here, because this is where popular coverage overreaches. The measured effects are single-digit to low-double-digit percentage changes in oxygenation markers in small samples. That is a genuine physiological advantage. It is not the "18% more oxygen" figure that circulates on social media, which does not trace back to any of these papers in the form it is usually quoted.

Mouth breathing is almost always downstream of something else. The distribution of causes matters because it determines which intervention is appropriate, and because occluding the mouth without addressing an obstructed nose is the specific scenario reviewers have flagged as dangerous.

• Adenoid hypertrophy has a reported prevalence of 49.7% in pediatric populations (Zhang et al., 2024).
• Allergic rhinitis affects 10-30% of US adults and up to 40% of children, accounting for 30 to 60 million people (StatPearls, NCBI Bookshelf).
• Nasal congestion is the single symptom most often rated "extremely bothersome" by allergic rhinitis patients, at 39% of respondents (Pediatric Allergies in America survey).
• Allergic rhinitis is estimated to cause a 30% productivity loss on a child's most symptomatic days and more than 2 million missed school days per year in the US.
• Breastfeeding shows a protective association (OR 0.62; 95% CI 0.41-0.93), with the caveat the authors attach to it (Savian et al., 2021).

A fast-growing claim in the athletic community, and one where the trial evidence is more equivocal than the marketing. Adaptation status appears to determine the result.

• In recreational runners who had already spent an extended period training with nasally restricted breathing, there was no significant difference in VO2max or time to exhaustion between nasal and oral breathing (Dallam et al., Int J Kinesiol Sports Sci 2018).
• The same study did find significantly better physiological economy and lower ventilatory equivalents for oxygen and carbon dioxide during steady-state work at 85% of maximal velocity under nasal breathing.
• In subjects not adapted to nasal-only breathing, exclusively nasal breathing significantly reduced peak exercise capacity and peak VO2 (BreathWISE, PLOS One).
• In well-trained cyclists and triathletes, a randomized cross-over found no significant differences in cardiopulmonary or performance parameters between breathing modes (randomized cross-over study, 2025).

Reading across the three: nasal breathing does not raise your ceiling, and it may lower it if you have not adapted. What it appears to improve is efficiency at submaximal intensity. That is a real but narrow claim, and narrower than most nasal-breathing marketing implies.

Mouth taping went from a niche practice to a retail category in about three years. The evidence base did not grow with it. This section is the one most likely to be cited, so the numbers are stated precisely.

• A 2025 systematic review searched February 1999 to February 2024 and found 10 studies with 213 patients in total (Rhee et al., PLOS One 2025).
• All 10 studies were rated poor quality on the Newcastle-Ottawa scale.
• Only two studies showed statistically significant AHI improvement, both in mild OSA only (AHI < 15): median AHI 8.3 to 4.7 per hour in one, 12 to 7.8 per hour in the other. Three studies found no significant change in AHI, and one found a mandibular advancement device alone outperformed the device combined with mouth taping.
• Four of the ten studies explicitly discussed serious hazards. The authors' wording: occlusion "could pose a serious risk of asphyxiation in the presence of nasal obstruction or regurgitation."
• Search interest tells the commercial story: Google Trends data shows 340% growth in "mouth tape" and 280% in "mouth taping" since early 2022 (Glimpse, Google Trends analysis).

The asymmetry is the story. A category growing at triple-digit rates, resting on 213 patients of uniformly poor-quality evidence, for an intervention whose main documented risk is the exact population most likely to try it: people who cannot breathe through their nose.

Treatment evidence for mouth breathing specifically is thinner than treatment evidence for sleep apnea, because most trials measure AHI rather than breathing route. Where a study measured breathing route directly, that is noted.

• Myofunctional therapy reduced AHI by approximately 50% in adults and 62% in children in the foundational meta-analysis (Camacho et al., Sleep 2015).
• A systematic review of nine randomized trials (n = 698, 2009-2020) found myofunctional therapy, alone or adjunctive, reduced AHI versus control in both adults and children (Exploration of Medicine).
• Measuring breathing route directly, one trial reported 38% of children completing myofunctional therapy achieved correct closed-lip posture versus 25% of untreated controls (controlled trial in mixed-dentition children).
• Rapid maxillary expansion produces significant increases in nasal cavity volume and upper airway dimensions, with reported AHI reductions and improved oxygen saturation (systematic review, 2021).
• The durability caveat on RME is real: one study found inspiratory nasal resistance returned to baseline 90 days after expansion, and another found resistance back at baseline by 30 months of follow-up. The systematic review concluded long-term benefit "could not be proved so far."
• Adenotonsillectomy improved behavior, quality of life, symptoms, and polysomnographic measures versus watchful waiting in the randomized Childhood Adenotonsillectomy Trial, but did not significantly improve the primary attention and executive function endpoint.

The column that matters most is the second one. Sorting interventions by the size and quality of their evidence base produces a very different ranking than sorting them by how often they are discussed online.

Sources for every figure in this table are linked in the treatment section and the mouth taping section above.